New York, August 09, 2024 - PRISM MarketView - PRISM Emerging Healthcare Index leader Aveanna Healthcare Holdings (AVAH) closed up 32% yesterday after delivering a strong second quarter in 2024, reporting $505.0 million in revenue—a 7.0% increase over the prior year. The home healthcare services company also saw a notable 27.3% rise in Adjusted EBITDA, reaching $45.6 million, underscoring the success of its Strategic Transformation initiatives. Despite a slight decrease in net income compared to last year, Aveanna’s Adjusted Net Income grew by $6.6 million, highlighting improved operational efficiency. With these results, Aveanna has raised its full-year 2024 revenue and Adjusted EBITDA guidance, reflecting positive momentum and confidence in its value-based home care model.
“Based on the strength of our second quarter and year-to-date results and the continued execution of our key strategic initiatives, we now expect full year 2024 revenue to be greater than $1.985 billion and adjusted EBITDA to be greater than $158 million. We believe our enhanced outlook provides a prudent view considering the challenges we still face with the evolving labor market and hopefully, it proves to be conservative as we continue to execute throughout the year.”
Aveanna’s CEO Jeff Shaner
About PRISM MarketView:
Established in 2020, PRISM MarketView is dedicated to the monitoring and analysis of small cap stocks in burgeoning sectors. We deliver up-to-the-minute financial market news, provide comprehensive investor tools and foster a dynamic investor community. Central to our offerings are proprietary indexes that observe emerging sectors, including biotech, clean energy, next-generation tech, medical devices and beyond. Visit us at prismmarketview.com and follow us on X.
Disclaimer:
PRISM MarketView is not a registered or licensed broker-dealer or investment adviser and does not offer investment advice. The information provided in this communication is not intended to constitute an offer to sell, a solicitation of an offer to buy, or a recommendation for any security.
Contact:
Prism MarketView | Stock Market News & Investment Opportunities